Page 1 | Search Results | Blood | American Society of Hematology

1-16 of 16

Sort by

Sort Order Select

Journal Articles

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Blood (2009) 113 (5): 995–1001.

https://doi.org/10.1182/blood-2008-05-160200

Published: 2009

Journal Articles

Re-Evaluation of Prognostic Value of Seric LDH and β2-Microglobulin Levels among 248 CLL with a Median Follow-Up Time More Than 6 Years.

Bernard Desablens, Réda Garidi, Bérengère Gruson, Iona Vaida, Marie Brevet

Blood (2006) 108 (11): 4441.

https://doi.org/10.1182/blood.V108.11.4441.4441

Published: 2006

Journal Articles

Long-Term Prognostic Value of Hematological and “Old” Biological Parameters in CLL. Reflexions on 156 Patients with a Median Follow-Up Time More Than 6.5 Years.

Réda Garidi, Ioana Vaida, Jean-Claude Capiod, Salhia Sid Idris, Bernard Desablens

Blood (2006) 108 (11): 4951.

https://doi.org/10.1182/blood.V108.11.4951.4951

Published: 2006

Journal Articles

Prognostic Value of Seric Immunoglobulins in CLL: Analysis of 331 Patients with a Median Follow-Up Time of 7.5 Years.

Réda Garidi, Marie-Noëlle Guilhaume, Ioana Vaida, Marie Brevet, Jean-Claude Mazière, Bernard Desablens

Blood (2006) 108 (11): 4961.

https://doi.org/10.1182/blood.V108.11.4961.4961

Published: 2006

Journal Articles

The VIP-ABVD Regimen Is Not Superior to the CHOP 21 for the Treatment of Non Epidermotropic Peripheral T Cell Lymphoma. Final Results of the “LTP95” Protocol of the GOELAMS.

Blood (2006) 108 (11): 2464.

https://doi.org/10.1182/blood.V108.11.2464.2464

Published: 2006

Journal Articles

Clinical Features and Prognostic Factors in 135 NHL of the Head and Neck Treated by the GOELAMS 02 Trial.

Laurent Laccourreye, MD, Bernard Desablens, MD, Christine Le Maignan, MD, Anne Le Mevel, MD, Christian Berthou, MD, Thierry Lamy, MD-PhD, Christiane Ghandour, François Guilhot, MD, Mathilde Hunault-Berger, MD-PhD, Henry Jardel, MD, Norbert Ifrah, MD, Philippe Colombat, MD, The GOELAMS Group

Blood (2005) 106 (11): 942.

https://doi.org/10.1182/blood.V106.11.942.942

Published: 2005

Journal Articles

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

Blood (2005) 105 (10): 3817–3823.

https://doi.org/10.1182/blood-2004-10-3920

Published: 2005

Journal Articles

High Dose and Conventional Anthracycline Regimen for Adult Non-Hodgkin’s Primary Bone Lymphoma (PBL). A GOELAMS’s Trial.

Aline Schmidt-Tanguy, MD, Bernard Desablens, MD, Thierry Lamy, MD-PhD, Marc Bernard, MD, Delphine Senecal, MD, Jean-Francois Abgrall, MD, Philippe Casassus, MD, Jacqueline Dugay, MD, Philippe Rodon, MD, Mathilde Hunault-Berger, MD-PhD, Norbert Ifrah, MD, the GOELAMS Group, Philippe Colombat, MD-PhD

Blood (2004) 104 (11): 2495.

https://doi.org/10.1182/blood.V104.11.2495.2495

Published: 2004

Journal Articles

ZAP-70 Tyrosine Kinase Is Constituvely Expressed and Phosphorylated in B-Lineage Acute Lymphoblastic Leukemia Cells.

Nicolas Guillaume, Celine Alleaume, Jean-Claude Capiod, Brigitte Pautard, Bernard Desablens, Jean-François Claisse, Jean-Jacques Lefrere, Fabrice Gouilleux, Kaiss Lassoued, Valerie Gouilleux-Gruart

Blood (2004) 104 (11): 1898.

https://doi.org/10.1182/blood.V104.11.1898.1898

Published: 2004

Journal Articles

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation

Pierre Feugier, Eric Labouyrie, Malika Djeridane, Arash Jenabian, Viviane Dubruille, Christian Berthou, Christiane Ghandour, Bernard Desablens, Yasmine Chaït, Philippe Casassus, Vincent Delwail, Norbert Ifrah, Annick Le Mevel, Thierry Lamy, Josette Brière, Pierre Colonna, Jean-Marie Andrieu

Blood (2004) 104 (9): 2675–2681.

https://doi.org/10.1182/blood-2004-02-0567

Published: 2004

Journal Articles

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial

Christine le Maignan, Bernard Desablens, Vincent Delwail, Mahmoud Dib, Christian Berthou, Magda Vigier, Christiane Ghandour, Saïd Atmani, Philippe Casassus, Hervé Maisonneuve, Annick Le Mevel, Catherine Traullé, Marc Bernard, Josette Brière, Pierre Colonna, Jean-Marie Andrieu

Blood (2004) 103 (1): 58–66.

https://doi.org/10.1182/blood-2003-05-1611

Published: 2004

Journal Articles

Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease

Véronique Leblond, Vincent Lévy, Frédéric Maloisel, Bruno Cazin, Jean-Paul Fermand, Jean-Luc Harousseau, Liliane Remenieras, Raphaël Porcher, Martine Gardembas, Gérald Marit, Eric Deconinck, Bernard Desablens, François Guilhot, Guilaine Philippe, Aspasia Stamatoullas, Odile Guibon

Blood (2001) 98 (9): 2640–2644.

https://doi.org/10.1182/blood.V98.9.2640

Published: 2001

Journal Articles

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

Michel Leporrier, Sylvie Chevret, Bruno Cazin, Najda Boudjerra, Pierre Feugier, Bernard Desablens, Marie-José Rapp, Jerome Jaubert, Claudie Autrand, Marine Divine, Brigitte Dreyfus, Karim Maloum, Philippe Travade, Guillaume Dighiero, Jacques-Louis Binet, Claude Chastang

Blood (2001) 98 (8): 2319–2325.

https://doi.org/10.1182/blood.V98.8.2319

Published: 2001

Journal Articles

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

Blood (1999) 94 (4): 1192–1200.

https://doi.org/10.1182/blood.V94.4.1192

Published: 1999

Journal Articles

A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients

Blood (1998) 91 (8): 2722–2730.

https://doi.org/10.1182/blood.V91.8.2722.2722_2722_2730

Published: 1998

Journal Articles

Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia

Blood (1997) 90 (8): 2978–2986.

https://doi.org/10.1182/blood.V90.8.2978

Published: 1997

NARROW

High-dose therapy followed by autologous purged stem cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by the GOELAMS with final results after a median follow-up of 9 years

Re-Evaluation of Prognostic Value of Seric LDH and β2-Microglobulin Levels among 248 CLL with a Median Follow-Up Time More Than 6 Years.

Long-Term Prognostic Value of Hematological and “Old” Biological Parameters in CLL. Reflexions on 156 Patients with a Median Follow-Up Time More Than 6.5 Years.

Prognostic Value of Seric Immunoglobulins in CLL: Analysis of 331 Patients with a Median Follow-Up Time of 7.5 Years.

The VIP-ABVD Regimen Is Not Superior to the CHOP 21 for the Treatment of Non Epidermotropic Peripheral T Cell Lymphoma. Final Results of the “LTP95” Protocol of the GOELAMS.

Clinical Features and Prognostic Factors in 135 NHL of the Head and Neck Treated by the GOELAMS 02 Trial.

High-dose therapy followed by autologous purged stem-cell transplantation and doxorubicin-based chemotherapy in patients with advanced follicular lymphoma: a randomized multicenter study by GOELAMS

High Dose and Conventional Anthracycline Regimen for Adult Non-Hodgkin’s Primary Bone Lymphoma (PBL). A GOELAMS’s Trial.

ZAP-70 Tyrosine Kinase Is Constituvely Expressed and Phosphorylated in B-Lineage Acute Lymphoblastic Leukemia Cells.

Comparison of initial characteristics and long-term outcome of patients with lymphocyte-predominant Hodgkin lymphoma and classical Hodgkin lymphoma at clinical stages IA and IIA prospectively treated by brief anthracycline-based chemotherapies plus extended high-dose irradiation

Three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) or epirubicin, bleomycin, vinblastine, and methotrexate (EBVM) plus extended field radiation therapy in early and intermediate Hodgkin disease: 10-year results of a randomized trial

Multicenter, randomized comparative trial of fludarabine and the combination of cyclophosphamide-doxorubicin-prednisone in 92 patients with Waldenström macroglobulinemia in first relapse or with primary refractory disease

Randomized comparison of fludarabine, CAP, and ChOP in 938 previously untreated stage B and C chronic lymphocytic leukemia patients

A Randomized Comparison of All Transretinoic Acid (ATRA) Followed by Chemotherapy and ATRA Plus Chemotherapy and the Role of Maintenance Therapy in Newly Diagnosed Acute Promyelocytic Leukemia

A Placebo-Controlled Study of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor Administered During and After Induction Treatment for De Novo Acute Myelogenous Leukemia in Elderly Patients

Comparison of Autologous Bone Marrow Transplantation and Intensive Chemotherapy as Postremission Therapy in Adult Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only